Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Treatment during development affects hormone balance and sexual behavior in male rats.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Finasteride may improve prostate cancer treatment outcomes.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Finasteride side effects in young men may be linked to specific gene variations.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Dutasteride and finasteride affect different cell types differently.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

We need better ways to test and understand SARMs to make safer and more effective treatments.